CDMO Blog

close

Categories

See More

Subscribe to Email Updates

Popular Stories

Viral Aggregation in Downstream Processing of Lentiviral Vectors
IQ, OQ and PQ: Why Are They Important in the Manufacturing of Cell and Gene Therapies?
Understanding the Role of the Quality Unit in Good Manufacturing Practices
The Canadian Regulatory System for Cell and Gene Therapies
Planning Is Everything - Quality Control Testing in Cell and Gene Therapy
09 Jun 2021

Scaling-Up Production of Pluripotent Stem Cells Part 2 – Key Considerations for Successful Scale-Up

In Part 1 of this series we covered some basic definitions and reviewe...

04 Mar 2021

5 Considerations for Scaling-Up PSC-Derived Cell Therapies

A core regenerative medicine approach is cell replacement for the repa...

24 Oct 2019

How Can a Closed CAR-T Manufacturing Process De-Risk Your Process, Reduce Costs and Improve Efficiency?

In a previous post we introduced chimeric antigen receptor T-cell (CAR...

24 Oct 2019

What is a Bioreactor and How is it Used in Cell and Gene Therapy?

Simply put, a bioreactor is a stand-alone cell culture vessel enabled ...

22 Oct 2019

How Can a Contract Development and Manufacturing Organization (CDMO) Advance a Cell & Gene Therapy Product?

  Making the Decision to Engage a CDMO

Tell us what you thought about this post.